Furthermore, in vivo experiments using a colon cancer xenograftmodel demonstrated that DOX@MSNP-BA-Tf effectively inhibited tumorgrowth, showing superior efficacy compared to free DOX and MSNP-BA-Tfalone. Here, TF is linked to colonic neoplasm.